Ignyte Acquisition
Why Robinhood?
You can watch IGNY and buy or sell other stocks, ETFs, and their options commission-free!About IGNY
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.
IGNY Key Statistics
Stock Snapshot
As of today, Ignyte Acquisition(IGNY) shares are valued at $0.02. The company's market cap stands at 520.3K, with a P/E ratio of -0.14.
On 2026-08-07, Ignyte Acquisition(IGNY) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 6.61K.
Over the past 52 weeks, Ignyte Acquisition(IGNY) stock has traded between a high of $0.26 and a low of $0.00.
Over the past 52 weeks, Ignyte Acquisition(IGNY) stock has traded between a high of $0.26 and a low of $0.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.